NOOS

Innovazione & Ricerca

  • Home
  • Company
  • Products
    • Immunitary
    • Oral cavity
    • Gastrointestinal
    • Respiratory
  • Contacts
  • en
https://www.noosit.com/wp-content/uploads/2017/11/VIDEO-ELITE.mp4
“Nóos Srl is a pharmaceutical company founded in 1999; drawing upon its founders’ extensive expertise in the pharmaceutical field, the company wanted to bring to the field of supplements and medical devices the same scientific approach and the focus on quality that is required for prescription drugs. These values have been acknowledged and appreciated by the specialists to whom they have been proposed and physicians have trusted the company, welcoming the presented therapeutic proposals with extreme interest. Nóos has always been committed to researching innovative products in the interests of Pediatricians, Neonatologists, Otolaryngologists, Gastroenterologists and Allergists. Nóos immediately understood the importance of probiotics in the management of the health and well-being of the body, anticipating the interest in this field that arose in the following years becoming increasingly important. The use of probiotics is a real revolution since, until a few years ago, the majority of diseases were mainly treated with antibiotics; today, however, antibiotics are “on trial” because of their excessive use, even when they were unnecessary. Revolution implies a new approach to many diseases, based on the well-established principle according to which the stimulation of the immune system makes the body biologically able to respond to external stimuli. Nowadays probiotics are not only intended as adjuvants in the treatment of diarrhea, a role in which they were restricted in the past, but they also find indications in much more complex diseases. Another factor for the success of Nóos was the investment in research; this led to the acquisition of international patents in the treatment of some respiratory diseases and in the area of food supplements. These values allowed Nóos to gain the esteem of the medical profession and to build important and strategic relationships with many international companies”

Dr. Giancarlo MORETTI
CEO

 

 

2003. Nóos signed an exclusive concession contract for Italy with BioGaia AB for the probiotic Lactobacillus reuteri DSM 17938; the product is launched on the Italian market under the trademark “Reuterin®“.  Scientific research and clinical development are always on-going.

 

2004. Nóos signed a sub-licensing contract with Italchimici SpA for the probiotic Lactobacillus reuteri DSM 17938 in Italy. The product was launched on the Italian market under the trademark “Reuflor®“. In 2016 Italchimici SpA entered the Recordati SpA group.

 

2012. Nóos submitted an international patent and launched a product line in the respiratory field for the Italian market: this was the result of its own scientific research. The products are registered under the trademark “LinfoVir plus®“.

 

2014. Nóos signed a distribution contract with Norgine Italia Srl for the distribution of “Movicol Bambini®” in Italy.

 

2017. Nóos entered Elite project which is an innovative platform created by the Italian Stock Exchange to offer services dedicated to ambitious companies willing to get in touch with a community of excellence; the project allows companies to deal with the best international models and the best practices to seize all the business opportunities.



Nóos S.r.l. is a pharmaceutical company aiming to the promotion and the development of pharmaceutical products, food supplements, medical devices and food for special purpose. Founded in 1999 the company Nóos has always been committed to researching probiotics and food supplements in the interests of Pediatricians, Neonatologists, Otolaryngologists, Gastroenterologists and Allergists.

© Copyright - Noosit.com. All Rights Reserved.

 Nóos S.r.l.
 Via Campello sul Clitunno, 34 00181 Roma – Italia

 Tel.: +39 06 78359730
 Fax.: +39 06 78345480
 info@noosit.com

VAT 05332161008
Share Capital: € 100.000

Privacy Policy

NOOS È ASSOCIATA A


W3Schools


W3Schools


W3Schools


W3Schools